Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Bladogra vs Myrbetriq in Healthy Volunteers
NCT04476966Phase 1Completed
- Sponsor
- Genuine Research Center
- Start
- Jan 2020
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of mirabegron in overactive bladder (OAB) (3 arms), sponsored by Genuine Research Center. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve to the last measurable concentration. Started Jan 2020; status: completed.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT04476966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04476966.